Metraipolis › archive › dc_b9c8df6cc8dd
The sodium/glucose cotransporter 2 inhibitor empagliflozin is a pharmacological chaperone of cardiac Nav1.5 channels — Europe PMC PMID:40796268
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40796268
- DOI
- 10.1152/ajpheart.00363.2025
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T17:26:02.217Z
- SHA-256 of the archived text
d68a2f960a00d9b91c7bf768cafb891c4c840c9134c00215519ff0202ae10231- Stable URL of this page
https://metraipolis.com/documento/dc_b9c8df6cc8dd
How to cite
The sodium/glucose cotransporter 2 inhibitor empagliflozin is a pharmacological chaperone of cardiac Nav1.5 channels — Europe PMC PMID:40796268 — Europe PMC (en), https://europepmc.org/article/MED/40796268 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b9c8df6cc8dd (Metraipolis archive dc_b9c8df6cc8dd, sha256 d68a2f960a00d9b91c7bf768cafb891c4c840c9134c00215519ff0202ae10231)
BibTeX
@misc{dcb9c8df6cc8dd,
title = {The sodium/glucose cotransporter 2 inhibitor empagliflozin is a pharmacological chaperone of cardiac Nav1.5 channels — Europe PMC PMID:40796268},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40796268},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b9c8df6cc8dd; sha256 d68a2f960a00d9b91c7bf768cafb891c4c840c9134c00215519ff0202ae10231},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40796268. Agents can read the archived copy with the MCP tool read_document.